"Latest Insights on Executive Summary Denosumab Market Share and Size
Data Bridge Market Research analyses that the global denosumab market which was USD 2,892.17 million in 2022, would rocket up to USD 7,109.92 million by 2030, and is expected to undergo a CAGR of 11.9% during the forecast period.Denosumab Market report presents the best market opportunities available and efficient...
Introduction
The Global Denosumab Market is expanding steadily as the demand for effective treatments for osteoporosis, bone loss associated with cancer, and other skeletal disorders rises worldwide. Denosumab is a monoclonal antibody drug that works by inhibiting RANKL (Receptor Activator of Nuclear factor Kappa-Β Ligand), a protein involved in bone resorption. By blocking this...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Tiếng Việt